SI-BONE, Inc. (SIBN) Dividend History

SI-BONE, Inc. is a medical device company specializing in minimally invasive solutions for the treatment of musculoskeletal disorders of the sinonasal and sacroiliac joint regions. The company develops and commercializes products designed to improve patient outcomes by addressing conditions related to the pelvis and sacroiliac joint, with a focus on innovative, image-guided procedures.

471 El Camino Real, Suite 101, Santa Clara, CA, 95050
Phone: (408) 207-0700
Website: https://www.si-bone.com

Dividend History

SI-BONE, Inc. currently does not pay dividends

Company News

4 Recent Earnings Winners Riding Fresh Momentum in May

Four under-the-radar companies - Porch Group, SunOpta, Tutor Perini, and Si-Bone - reported strong earnings in Q1 2025 and are seeing positive momentum in May.

Investing.com

Featured Companies: PRCH STKL TPC
Here's Why You Should Add Inogen Stock to Your Portfolio Now

Inogen is well-positioned for growth in the portable oxygen concentrator (POC) market, with a strong product portfolio and solid Q2 results. However, it faces stiff competition and forex volatility. The company's stock has outperformed the industry and the S&P 500 year-to-date.

Benzinga

Featured Companies: AXGN INGN
SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

SI-BONE, Inc. (SIBN) announced that it will be participating in the upcoming Morgan Stanley Global Healthcare Conference, where management will host a fireside chat on September 4, 2024.

GlobeNewswire Inc.
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates

Si-Bone (SIBN) delivered earnings and revenue surprises of 6.90% and 3.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Featured Companies: WAT

Page data last updated 07/22/2025 18:58:43 UTC